NIH awards VeraChem Phase II SBIR funding for VM2 parallelization

NIH awards VeraChem Phase II SBIR funding for VM2 parallelization

Phase I milestones successfully completed, NIH awards VeraChem Phase II funding for the SBIR titled, “Multilevel Parallelization of Software for Accurate Protein-Ligand Affinities.”